GRM5 and Alzheimer disease: Our previous work using [18F]FPEB and [11C]UCB-J PET showed that both mGluR5 binding and synaptic density are significantly lower in the medial temporal lobe of individuals with AD with largest effect sizes in the hippocampus [13].